Posted in | News | Nanomaterials | Graphene | Nanobusiness

CTI Nanotechnologies Provides Update on Graphene Paper Progress

Download PDF Copy

Editorial Checklist

Reviewed

May 27 2014

American Graphite Technologies Inc. is pleased to announce it has received updates from Mike Foley, CEO of CTI Nanotechnologies LLC on its graphene paper progress.

Mr. Foley reports he has made considerable progress with his aqueous formulation from recent development initiatives. The previous best conductivity for the aqueous formulation was 35 ohms. Current results are showing less than 15 ohms representing a greater than 100% improvement in conductivity. Mr. Foley stated, "This substantial reduction in resistivity through our research and development efforts is an extremely positive development. Process, plant and equipment engineering are all ongoing, but we are excited to see the progress being made."

Mr. Foley also reported that the two production lines have been moved to the new facility. The small, 12-inch wide line is close to operational and the large 30-inch wide line should be operational by fourth quarter 2014.

Source:

http://americangraphitetechnologies.com

Download PDF Copy

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback

Public Comment

Private Feedback to AZoNano.com

Submit

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.